Abstract:In drug development, the efficacy of an antibody depends on how the antibody interacts with the target antigen. The strength of these interactions gives an indication of how successful an antibody is in neutralizing an antigen. Therefore, the strength, measured by “binding affinity”, is a critical aspect of antibody engineering. In theory, the higher the binding affinity, the higher the chances are that the antibody is successful against the target antigen. Currently, techniques such as molecular docking and molecular dynamics are utilized in quantifying the binding affinity. However, owing to the computational complexity of the aforementioned techniques, running simulations for large antibodies/antigens remains a daunting task. Despite the commendable improvements in deep learning-based binding affinity prediction, such approaches are highly dependent on the quality of the antibody-antigen structures and they tend to overlook the importance of capturing the evolutionary details of proteins upon mutation. Further, most of the existing datasets for the task only include antibody-antigen pairs related to one antigen variant and, thus, are not suitable for developing comprehensive data-driven approaches. To circumvent the said complexities, we first curate the largest and most generalized datasets for antibody-antigen binding affinity prediction, consisting of both protein sequences and structures. Subsequently, we propose a deep geometric neural network comprising a structure-based model and a sequence-based model that considers both atomistic and evolutionary details when predicting the binding affinity. The proposed framework exhibited a 10% improvement in mean absolute error compared to the state-of-the-art models while showing a strong correlation between the predictions and target values. We release the datasets and code publicly ( ) to support the development of antibody-antigen binding affinity prediction frameworks for the benefit of science and society.

AttABseq: an Attention-Based Deep Learning Prediction Method for Antigen-Antibody Binding Affinity Changes Based on Protein Sequences.

Sequence-based deep learning antibody design for in silico antibody affinity maturation

AlphaBind, a Domain-Specific Model to Predict and Optimize Antibody-Antigen Binding Affinity

AbAgIntPre: A Deep Learning Method for Predicting Antibody-Antigen Interactions Based on Sequence Information

Improved deep learning prediction of antigen-antibody interactions

A Comparison of Antibody-Antigen Complex Sequence-to-Structure Prediction Methods and their Systematic Biases

Antibody optimization enabled by artificial intelligence predictions of binding affinity and naturalness

AntiFormer: graph enhanced large language model for binding affinity prediction

DDAffinity: predicting the changes in binding affinity of multiple point mutations using protein 3D structure

Accurate Prediction of Antibody Function and Structure Using Bio-Inspired Antibody Language Model

The Accurate Prediction of Antibody Deamidations by Combining High-Throughput Automated Peptide Mapping and Protein Language Model-Based Deep Learning

abCAN: a Practical and Novel Attention Network for Predicting Mutant Antibody Affinity

MVSF-AB: Accurate antibody-antigen binding affinity prediction via multi-view sequence feature learning

DEAttentionDTA: protein–ligand binding affinity prediction based on dynamic embedding and self-attention

The RESP AI model accelerates the identification of tight-binding antibodies

SAM-DTA: a sequence -agnostic model for drug-target binding affinity prediction

Interpretable antibody-antigen interaction prediction by introducing route and priors guidance

Deep Geometric Framework to Predict Antibody-Antigen Binding Affinity

Antibody Representation Learning for Drug Discovery

Development and experimental validation of computational methods for human antibody affinity enhancement